Results 141 to 150 of about 88,182,083 (298)

Addressing in‐hospital substance use: A bioethical evaluation of two possible approaches

Journal of Hospital Medicine, EarlyView.
Abstract Up to 40% of patients with substance use disorder report using non‐prescribed drugs when hospitalized. In‐hospital substance (IHSU) use is associated with poor outcomes and raises safety concerns for healthcare providers. Despite its prevalence, little guidance exists regarding best practices in responding to IHSU.
John C. Messinger, Taylor Baisey, Johanna Sluser, Benjamin A. Barsky, Marlene Martin, Leslie W. Suen   +5 more
wiley   +1 more source

Use of Medications for Opioid Use Disorder and Child Welfare Outcomes

JAMA Health Forum
This cohort study investigates whether use of medications for opioid use disorder in pregnancy is associated with higher rates of infants discharge home with their mothers after birth.
Muhar, Alexandra, McNeer, Elizabeth, Presley, Lauren D., Morad, Anna, Loch, Sarah F., Dupont, William D., Patrick, Stephen W.   +6 more
openaire   +2 more sources

Linking people with opioid use disorder to medication treatment : a technical package of policy, programs, and practices [PDF]

Millions of Americans are living with opioid use disorder (OUD). Fortunately, medications for opioid use disorder (MOUD) approved by the Food and Drug Administration can effectively treat OUD, reduce illicit opioid use or prescription opioid misuse, and ...

core  

Association between xerostomia and peri‐implant health: A retrospective cohort study

Journal of Periodontology, EarlyView.
Abstract Background Dental implants are a long‐term and reliable solution to replace missing dentition, but subject to different patient‐related and biological changes that could alter its success. Xerostomia, or the alteration of the normal salivary flow, can impair oral function and potentially affect the success of any treatment, including implant ...
Shahad Alhazmi, Sahar Baniameri, Parham Hazrati, Yousef Amrou, Fatemeh SamavatiJame, Hom‐Lay Wang, Muhammad H. A. Saleh   +6 more
wiley   +1 more source

Patient perspectives of jail based MOUD treatment: views of individuals who have returned to the community following incarceration

Health & Justice
Background Massachusetts passed legislation in 2018 to mandate provision of medications for opioid use disorder (MOUD) in select jails to address the high risk of opioid overdose after release.
Claudia Santelices, Warren Ferguson, Rebecca Rottapel, Ekaterina Pivovarova, Elizabeth Evans, Thomas Stopka, Peter Friedmann   +6 more
doaj   +1 more source

Physician’s Attitudes Toward Patients With Opioid Use Disorder and Use of Medications for Opioid Use Disorder Vary by Training

Substance Use & Addiction Journal
Objectives: This study compared whether different addiction treatment educational experiences were associated with physicians’ attitudes toward patients with opioid use disorder (OUD) and perceived efficacy of medications for opioid use disorder (MOUD ...
Bridget C. Bailey, Helen Anne Sweeney, Erin L. Winstanley, Christopher Lopez, Laura Potts   +4 more
openaire   +2 more sources

Moving toward evidence-based programs: medication-assisted treatment for opioid use disorder in Utah

, 2020
policy reportDrug overdose is the leading cause of injury death in Utah, i and opioid-related drug overdoses are a significant contributor to the rise in drug overdose deaths in recent history.
Kem C. Gardner Policy Institute
core  

A comparative analysis of the prevalence of medicine classes and polypharmacy between community‐dwelling and residential aged care populations in Western Australia

Journal of Pharmacy Practice and Research, EarlyView.
Abstract Background Polypharmacy is a global issue, particularly among residential aged care home (RACH) residents with multimorbidity and complex care needs. However, population‐level evidence on longitudinal trends and comparisons with community‐dwelling (CD) older adults remains limited.
David Lim, Ninh Ha, David Youens, Rachael Moorin, Andrew Stafford   +4 more
wiley   +1 more source

“HEAL together”: a randomized, hybrid type 1 effectiveness-implementation trial protocol of a peer-delivered behavioral activation intervention to improve methadone treatment retention

Frontiers in Public Health
BackgroundAlthough medications exist to effectively treat opioid use disorder (OUD), treatment retention is a pressing challenge. Peer recovery specialists (PRSs) may play an important role in OUD treatment retention, yet few evidence-based interventions
Jessica F. Magidson, Jessica F. Magidson, Valerie D. Bradley, Jessica S. Anane, Mary B. Kleinman, Julia W. Felton, Abigail C. Hines, Rithika Baskar, Aaron D. Greenblatt, Dwayne Dean, Morgan S. Anvari, Heather Fitzsimons, Melanie E. Bennett, Annabelle M. Belcher   +13 more
doaj   +1 more source

Providing Medication Assisted Treatment for Opioid Use Disorder in Family Medicine Clinics in Vermont

, 2016
Opioid use disorder is a nationwide issue and a serious problem in the state of Vermont. Medication assisted treatment (MAT) is currently being used to treat individuals with opioid use disorder. In an effort to address the opioid epidemic, more and more
Collier, Kelley W
core